Page last updated: 2024-09-04

cyc 202 and Cancer of Pancreas

cyc 202 has been researched along with Cancer of Pancreas in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Kizhake, S; Natarajan, A; Rana, S; Sonawane, YA; Taylor, MA; Zahid, M1
Cloyd, JM; Du, S; Mao, Y; Pawlik, TM; Xiao, Y; Xu, G; Zhang, B1
Chu, Q; Wang, L; Wang, W; Wang, Y; Zhang, J1
Lawrence, TS; Maybaum, J; Morgan, MA; Parsels, JD; Parsels, LA; Tanska, DM1
Andersen, JM; Caffrey, TC; Collisson, EC; Eggers, JP; Grandgenett, PM; High, RR; Hollingsworth, MA; Lewallen, ME; Ouellette, M; Singh, PK; Swanson, BJ; Tremayne, J1
Barth, P; Göke, R; Lankat-Buttgereit, B; Samans, B; Schmidt, A1
Alemany, C; Blasco, F; Calbó, J; Cascalló, M; Ciudad, CJ; Gómez, A; Hernández, JL; Masa, M; Mazo, A; Nicolás, M; Noé, V; Peñuelas, S; Pérez-Torras, S; Piulats, J; Soler, M; Tarrasón, G1

Other Studies

7 other study(ies) available for cyc 202 and Cancer of Pancreas

ArticleYear
Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy.
    Bioorganic & medicinal chemistry letters, 2018, 12-15, Volume: 28, Issue:23-24

    Topics: Amination; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship

2018
Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Surgical oncology, 2022, Volume: 44

    Topics: Aurora Kinase A; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genome-Wide Association Study; Humans; Lapatinib; Pancreatic Neoplasms; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); RNA; Roscovitine; Serine; Threonine; Trypsin

2022
CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation.
    Cancer medicine, 2021, Volume: 10, Issue:11

    Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 5; Dipeptides; Gene Silencing; Humans; Immunoprecipitation; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Receptor, Notch1; RNA, Messenger; Roscovitine; Signal Transduction

2021
The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.
    Cell cycle (Georgetown, Tex.), 2018, Volume: 17, Issue:9

    Topics: Analysis of Variance; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Deoxycytidine; DNA Replication; Gemcitabine; Histones; Humans; Nucleosides; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Roscovitine; Staining and Labeling

2018
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Oct-01, Volume: 17, Issue:19

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Disease Progression; Enzyme Activation; Gene Amplification; Genes, ras; Humans; Mutation; Neoplasm Invasiveness; Nerve Tissue Proteins; Pancreatic Neoplasms; Purines; Roscovitine

2011
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1).
    American journal of physiology. Cell physiology, 2004, Volume: 287, Issue:6

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoid Tumor; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Endocrine Gland Neoplasms; Female; Humans; Insulinoma; Lung Neoplasms; Male; Pancreatic Neoplasms; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Purines; Retinoblastoma Protein; RNA-Binding Proteins; Roscovitine

2004
Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy.
    Oncology, 2004, Volume: 67, Issue:3-4

    Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Decorin; DNA Primase; DNA-Binding Proteins; Down-Regulation; Extracellular Matrix Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, p16; Genetic Vectors; Histone Deacetylase 1; Histone Deacetylases; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Kinetin; Nuclear Proteins; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proteoglycans; Purines; Reverse Transcriptase Polymerase Chain Reaction; Roscovitine; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein

2004